Background. Acute kidney injury (AKI) recognition by clinicians has been shown to be suboptimal. Little work has focused on the use of an automated warning of a rise in a patient's creatinine, indicating AKI. Methods. Over 3 months in 2008 we ran a prospective observational study of 'alerts' sent by our Integrated Clinical Environment pathology system, identifying all patients with a ≥75% rise in their creatinine from its previous value. Information was collected on subsequent renal function, comorbidities and other potential predictors of survival. Results. In the 3-month period 463 adults with a first episode of AKI were identified by an alert; 87% were hospital inpatients. Median follow-up was 404 days. In-hospital mortality was 36% for those who were admitted. After performing Weibull survival analysis, significant predictors of poorer survival were the presence of metastatic, haematological or lower risk malignancy, a residential or nursing home address and higher age, number of non-malignant comorbidities or C-reactive protein level. Predictors of better survival were higher serum albumin level or nadir GFR during the episode and Indian subcontinent ethnicity. A receiver-operator curve for a prognostic score developed from the analysis showed an area under the curve of 0.84. Conclusions. The alerts identified a group of AKI patients who are at moderately high risk of death. The prognostic score using a combination of covariates shows early promise. Both the alerts and the score warrant further development as tools for earlier intervention in AKI.
Introduction
Acute kidney injury (AKI) is a common problem, affecting between 7 and 18% of hospital inpatients [1] [2] [3] . Most are managed by non-nephrologists. Concerns have been expressed about the care of hospitalized AKI patients in the UK [4] and USA [5] . In the UK 22 to 31% of AKI patients were referred to nephrologists [6, 7] , with a bias against referring older and more comorbid patients [7] . Furthermore, a recent National Confidential Enquiry into Patient Outcome and Death report highlighted delays and deficiencies in the management of a large cohort of patients dying from AKI in the UK [6] .
One approach to earlier identification of AKI patients is the use of the laboratory information system to warn of a creatinine rise in a given patient. Creatinine has, however, been widely criticized as a marker of AKI, as the rise in creatinine often takes a number of days to occur after the onset of AKI [8] . This is one reason for the growing interest in the use of alternative biological markers in the earlier diagnosis and intervention in AKI. However, in view of the concerns about AKI management (above), there is a case to be made that clinicians do not make good use of the currently available information indicating that a patient may have developed AKI. There have been two studies on use of laboratory information systems to warn of the development of AKI. One studied ITU patients [9] , and the other produced a reduction in the use of nephrotoxic medications in AKI [10] .
We used our laboratory information system to send an 'alert' warning of a rise in creatinine in any patient. In 2008 we carried out a prospective study of these alerts in our institution. This study focuses on the large group of patients with AKI who are outside of the renal ward or the intensive care unit. Our aims were to examine the features and prognosis of the group of patients identified by the alerts and to see if readily available information could be used to predict the survival of the patients.
Materials and methods
This prospective study ran from 9 AM on 17 September 2008 to 9 AM on 17 December 2008. We studied first episodes of AKI in adults aged 16 years and older, commencing within the study time period, as indicated by an 'alert' from the pathology system. The alert messaging system was set-up within the Integrated Clinical Environment (ICE) pathology man-agement software [Sunquest Information Systems (Europe) Ltd], used by two of the hospitals in our group (one of~720 beds, one of 250 beds).
The system sent an alert for any result which showed a ≥75% rise in creatinine from the previous creatinine value recorded for that patient. The previous or 'baseline' creatinine was the value immediately prior to the alert creatinine, and the former was at any timepoint in the past ranging from the same day to years previously. The peak creatinine was the highest creatinine with the episode of AKI [3, 11] , and the recovery creatinine was the lowest creatinine within 180 days of the peak. The RIFLE [12] or AKIN [13] stage for each patient was determined using the per cent rise from baseline to peak creatinine for the episode of AKI.
Our laboratory took part in the National External Quality Assessment Service (NEQAS) adjustment of the Modification of Diet in Renal Disease four-variable equation, using an isotope dilution mass spectrometry traceable version of the equation, and with NEQAS derived slope adjusters to the equation.
Patient details on the alert were recorded prospectively as part of the observational study. Patient referral was entirely at the discretion of their primary care or hospital clinician. Referred patients were managed in the usual way by the nephrology team. There were no visits to or intervention for unreferred patients. We were interested in the potential use of the alerts to modify the course of AKI, so we excluded patients who had already been referred for haemodialysis at the time of their first alert. According to National Research Ethics Service procedures, the project was classified as a service evaluation by the Heart of England NHS Trust Research and Development office and did not require separate ethical approval.
The postcode of the recorded admission address was used to determine a measure of deprivation [the Index of Multiple Deprivation (IMD) 2007 [14] ]. Clinical information on the cause of AKI and comorbidities was taken from the case records, both electronic and paper. The comorbidities classified by Charlson et al. [15] were used with minor modifications (see Supplementary data). Comorbidities were deemed present if found at admission or before onset of AKI.
Vital status follow-up concluded on 17 December 2009, 1 year after the final alert for the last patient entered into the study. Initial survival analysis was carried out using SPSS, version 17 (SPSS Inc.), with covariates as shown in the Supplementary data, Table 2 . Inflammatory marker values were collected retrospectively within 4 days either before or after the alert date. We used the albumin, C-reactive protein (CRP) and white cell count closest to the date of alert as being most representative of the clinical situation at the time of the alert.
To reduce the number of covariates [16] , we combined the total number of the non-malignant comorbidities in a simple arithmetic score. We excluded HIV/AIDS and connective tissue disease from the analysis on the basis of a prevalence of <2% in the study population. Data were missing for the laboratory variables collected retrospectively (albumin, CRP and total white cell count) for 3.5, 8.6 and 1.5% of patients, respectively.
Weibull survival analysis [17, 18] was carried out with Stata software (Stata Corp., College Station, TX, USA). This is a parametric proportional hazards model, and a decreasing hazard with time was postulated, with the shape parameter being <1.0. Patients with complete data were used for the Weibull model and prognostic index (PI) analysis. The model was reduced using stepwise methods. The coefficients from the Weibull analysis were used to create a PI as described [19] . The coefficient for each of the covariates in the model was divided by the smallest coefficient and rounded to the nearest integer, thus giving an integer score for each covariate, which allowed calculation of a PI for each patient, unique to their characteristics. To produce a log event time ratio [20] , the accelerated failure time (AFT) form of the Weibull model was used, where a coefficient (β) from the AFT model can be used to calculate the event time ratio, e β , for the corresponding dichotomous variable.
Results

Description of cohort
Over 3 months in 2008 764 alerts were received (Table 1) . Alerts for 463 adult patients with a first episode of AKI were further analysed. The baseline creatinine measure was taken as the median of 43 (interquartile range 7-216) days prior to the occurrence of the alert. Fifteen per cent of alert creatinines were within 2 days of a baseline creatinine. The source of the alerts was as follows: emergency department or acute admission ward 54%, other hospital wards 33% and outpatient clinic, primary care or hospice 13%. The alerts for inpatients with a first AKI episode (not already on dialysis) represented 3% of all admissions to the two hospitals (12 702 admissions excluding day case and paediatric admissions). This does not include outpatient episodes, further episodes of AKI or AKI patients already referred for dialysis at the time of the alert.
The patients with AKI were elderly and comorbid ( Table 2,Supplementary Table 1) . Median age was 75 years, and four patients were aged 16 to 17 years, the remainder being 18 years or over. Medical causes of AKI (pre-renal and intrinsic renal causes) predominated ( Table 3 ). The RIFLE/AKIN classification of the patients is shown in Table 4 . The alert creatinine was also the peak creatinine (the highest available creatinine during the AKI episode) in 75% of patients.
As a means of validation of the sensitivity of the alert, we looked at all AKI patients requiring dialysis in our hospital group, who were admitted via the two hospitals and dialysed during the time period of the study. Thirty-eight patients were admitted and dialysed during the study. Thirteen (34%) had an alert prior to dialysis, 22 (58%) had a gradual test-to-test rise in their creatinine below the 75% threshold and three (8%) had a creatinine value that was high at admission with no available baseline value.
Hospital admission and dialysis
Admission and survival to discharge numbers are given in Table 4 . Median follow-up was 404 days for censored survivors and 13 days for non-survivors. One hundred and fifty of the 414 patients (36%) who were admitted died during the admission. Dialysis utilization appeared low, with only 13 patients receiving dialysis, representing 2.8% of the entire group. At the end of follow-up 231 patients (49.9%) had died.
Functional recovery from AKI
Sixty-two patients survived <48 h from their alert time. Fifty-three patients survived more than 48 h after the alert but had no available follow-up creatinine values. In 348 patients surviving more than 48 h, the post-AKI GFR was compared with the pre-AKI GFR. Sixty of these (17%) had worsening of their CKD stage (in 47 their CKD progressed one stage, in 12 two stages and in 1 three stages). The remaining 288 patients had no deterioration in their CKD stage. Ninety-five of the 348 patients (27%) had a decline of over 15 mL/min/1.73 m 2 in their GFR.
Survival analysis, PI and event time ratio
In Kaplan-Meier survival analysis (Supplementary Table 2 ), higher age, non-Indian subcontinent ethnicity, admission from a residential or nursing home address, inpatient status at the time of the alert, lower baseline GFR, lower nadir GFR (Figure 1 ), lower albumin and higher CRP were all significantly associated with poorer survival. Among the 2162 M. Thomas et al.
comorbidities, the presence of a solid tumour (low risk or metastatic), a haematological malignancy and the total number of non-malignant comorbidities were each significantly associated with a poorer survival ( Figure 2 ). We substituted RIFLE/AKIN stage in place of nadir GFR. RIFLE performed less well in a univariate log-rank test (chi-square 8.1, P = 0.005, data not shown), compared with nadir GFR (chi-square 22.4, P < 0.001), and was not significant in the Weibull analysis (below). In further analyses, there was no significant difference between the two hospitals in Kaplan-Meier and Weibull survival analysis. We also found no difference in the survival analyses when we treated the three hospice patients as being in the residential/nursing home group (data not shown). White cell count quartile showed no effect on survival (Supplementary Table 2 ). The tenth decile of white cell count (≥26.0 × 10 9 /L) was associated with significantly poorer survival on Kaplan-Meier analysis, but this was not a significant predictor in the Weibull analysis (below; additional data not shown).
We carried out a Weibull analysis ( Table 5 ). The proportional hazards assumptions were met in the Weibull analysis. The time from baseline to alert creatinine was not a significant covariate in the Weibull analysis. Using a method to create a PI [19] , we looked at two prognostic models. The first model included all the significant variables (P < 0.1) in the Weibull analysis. This gave an area under the receiver-operator curve (AUROC) of 0.84 (0.80-0.88, P < 0.001, n = 417). In a second model, we omitted the IMD 2007, as it was of borderline significance and impractical in routine use. This gave an AUROC of 0.84 (0.80-0.87, P < 0.001, n = 417). Models with formal multiple imputation for the small amount of missing data resulted in very minor changes in the Weibull model. The mean of the scores for the 417 patients was −31 (SD 54, range −211-107). The highest quintile had a score of 13.7 or more. Across the five quintiles of the PI, the mortality rose progressively: 7.2, 35.7, 50.6, 65.5 and 92.8%. A cut-off of −25 gave a sensitivity of 70% and specificity of 76%. The PI in survivors and non-survivors and the receiver-operator curve are shown in Supplementary  Figures 1 and 2 . The AFT Weibull model allows an 'event time ratio' to be calculated directly from the coefficients generated [20] , more precisely than visual estimation from survival curves.
As an example, the AFT coefficient for a patient in a residential or nursing home was −1.27 (not shown), giving an event time ratio of e −1.27 , or 0.28. This indicates that the survival time was 72% less for a patient admitted from a residential or nursing home, compared to a patient admitted from a private home.
Discussion and Conclusion
There are no large studies of fully automated alerts using a creatinine rise to identify unselected AKI. One study was restricted to drug-induced AKI [10] , and another used a fixed creatinine level of ≥400 μmol/L to identify potential AKI cases [4] . Our study is a first step in addressing this area. It shows that use of these alerts is feasible and identifies patients at moderate to high mortality risk. We used a parametric Weibull model, which is more efficient than the semi-parametric Cox model, and can produce useful summary data such as the event time ratio [18, 20] . We developed a prognostic score for unselected patients using readily available covariates. Such a score or an evolution of this score could in future provide improved estimation of prognosis.
Uchino et al. [3] studied AKI in hospital admissions (mean age 64 years), with in-hospital mortality rates of 15, 29 and 41% for the risk, injury and failure categories of AKI. Among non-ITU patients with AKI (mean age 63 years), Liano et al. found 31% mortality [21] . With a mean age of 71 years, our inpatient mortality rate of 36% is roughly comparable.
There are important differences between our pragmatic approach and those of the ADQI and AKIN groups [12, 13] . We did not require that the baseline creatinine was within 48 h of the alert creatinine [12, 13] . This window was based on patients in intensive care or after major cardiothoracic surgery [13, 22, 23] . Eighty-five per cent of our unselected patients did not meet the narrow time interval of 48 h for the baseline creatinine at presentation with AKI. The number of days between the baseline and alert creatinines did not contribute to the survival model, suggesting that the interval did not hold any significant implications for prognosis.
The method of determining baseline creatinine has been studied recently [24, 25] . The ADQI group suggested that a baseline creatinine could be estimated, assuming a baseline GFR of 75 mL/min/1.73 m 2 . This imputed baseline creatinine leads to a false positive diagnosis of AKI in a minority of patients [24, 25] . In the presence of other prognostic factors, baseline GFR, its source (inpatient versus outpatient) and the time between baseline and alert creatinines were not independent predictors of prognosis. Overall the data from this and other works [24, 25] suggest that the approach of using a baseline creatinine from a narrow time window, or otherwise substituting an estimated baseline value, should be reconsidered.
Even minor episodes of AKI with small changes in creatinine of ≥0.5 mg/dL (44.2 μmol/L) have recently been shown to be associated with increased mortality [2, 22] . The progressive rise in mortality with falling nadir GFR In these patients who were not admitted, the cause of AKI was unclear from the information available from primary care. No patients were in the RIFLE F c class for acute on chronic kidney disease (baseline of ≥310 μmol/L and a rise of at least 44 μmol/L). Number at risk as shown at 100-day intervals; P < 0.001 by log-rank test. in our patients is consistent with those findings and studies of unselected hospital inpatients [3] . This and other work [26] suggest that the degree of renal failure per se is only one among many factors influencing outcome in patients with AKI. The finding that the RIFLE/AKIN stage performed less well in survival analysis than nadir GFR is not surprising, in that the latter used evenly split quartiles, whilst the former used three arbitrary and uneven groups. Staging remains useful as an indicator of the severity of AKI and a rough indication of the associated risk.
There has been little work looking at the effect of nonrenal comorbidities on outcome. Charlson comorbidities have been used to predict outcome in end-stage renal disease [27] [28] [29] . Charlson comorbidities are common in hospital wards and in the community, but there are no published AKI studies using them in survival analysis. Intensive care patients with AKI and uncontrolled malignancy are known to do poorly [30] . In this study, median survival in metastatic carcinoma was 15 days, with over 90% mortality within 6 months. Patients with haematological malignancy are known to do poorly if they develop AKI [31, 32] . Larger studies will be needed to look at the individual impact of all the non-renal Charlson comorbidities [16] .
There is evidence that AKI is a cytokine-mediated proinflammatory state, which influences distant organs [33] . Falling albumin levels may reflect this and are known to be significantly associated with worsening mortality [34, 35] . Lower albumin levels may also reflect malnutrition, which is also significantly associated with a poor outcome in AKI [36] .
There was a low rate of dialysis usage in our study. Fifteen per cent of patients with hospital-acquired AKI were dialysed in one US study [1] . In one study with average peak creatinine of 514 μmol/L among non-ITU inpatients with AKI, 18% were dialysed [21] . In the recent UK study of 551 patients dying with AKI, 12% received dialysis [6] . In another study, among AKI patients with a rise in creatinine to ≥300 μmol/L, 8% underwent dialysis [7] . Our study looked at more modest degrees of AKI, with 22% of patients having a peak creatinine of ≥300 μmol/L, and about 3% of patients underwent dialysis. Even allowing for the more modest degree of AKI in this study, a degree of under referral of patients could have contributed to some under usage of dialysis. The scores developed from studies of critically ill patients [37] rely on organ failure as prognostic indicators, when these are uncommon outside ITU [21] . Studies of AKI-specific models have included larger proportions of critically ill patients [38] [39] [40] than our work. Our PI performed reasonably well, with an area under the receiveroperator curve of 0.84, compared to 0.53 to 0.66 on the day of AKI diagnosis for one study of prognostic models (largely intensive care based) [37] . Our prognostic model will require a validation study before it can be used, but it does emphasize the question as to how much biomarkers will add to prognostic models such as this [41, 42] . Creatinine has drawbacks as a marker of AKI [8] , but at a population level it is likely to remain the first line screening test of kidney function for acutely ill patients. In this hospital group alone, over 650 000 creatinine tests were performed on adults ≥16 years of age over the year from April 2009 (personal communication, David Husband).
The strengths of our study include its unselected, consecutive and prospective cohort of AKI patients with substantial percentage rises in their creatinine, in whom detailed data were available on standardized comorbidities and other covariates. We did not use estimated baseline creatinine, but by definition had an actual baseline creatinine. This study is the first to use a Weibull survival analysis and the first to develop a PI for unselected patients with AKI.
The limitations of our study relate mainly to the relatively unsophisticated nature of the alert algorithm. To limit the number of alerts, we restricted them to patients with a ≥75% rise in creatinine and deliberately excluded smaller test-to-test rises in creatinine. We tended to pick up patients presenting to emergency areas with a big jump in their creatinine since their last test. The alerts identify large (and rising) numbers of patients with AKI. We re-examined the total numbers per day over 3 weeks in 2010 for the two hospitals (including 'false positive' alerts from dialysis and other patients), with these creatinine rises: ≥25, ≥50 and ≥ 75%. The mean (SD) numbers rose exponentially with lowering the cut-off, to 91 (43), 30 (15) and 16 (11) per day (respectively). This compares to 8 (4) per day with a ≥75% cut-off over the 3 months of the study in 2008. Dealing with such large numbers of alerts presents a challenge. Only one-third of patients later requiring dialysis were identified by a prior alert using a ≥75% cut-off. Lowering the percentage rise in creatinine required for an alert will make it more sensitive but also less specific with much larger numbers of alerts. More sophisticated algorithms will need to exclude known dialysis patients and use a mixture of creatinine rise and latest GFR level to limit the patients to those at moderate and higher risk.
In conclusion, automatic alerts and the prognostic index show promise in assisting earlier recognition and prognostication in AKI. Further work is needed to automatically but selectively identify at a population level the AKI patients at moderate to high risk of dialysis or death.
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